Literature DB >> 6132654

Alpha-blockers and converting enzyme inhibitors.

P C Rubin, J L Reid.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6132654      PMCID: PMC1547395          DOI: 10.1136/bmj.286.6372.1192

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

Review 1.  Captopril in the treatment of clinical hypertension and cardiac failure.

Authors:  A B Atkinson; J I Robertson
Journal:  Lancet       Date:  1979-10-20       Impact factor: 79.321

2.  Effects of the angiotensin converting enzyme inhibitor, captopril, in essential hypertension.

Authors:  B C Campbell; A N Shepherd; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

3.  Labetalol: the nineteen-eighties.

Authors:  J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

4.  Studies on the clinical pharmacology of prazosin. I: Cardiovascular, catecholamine and endocrine changes following a single dose.

Authors:  P C Rubin; T F Blaschke
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

5.  Low-dose captopril in chronic heart failure: acute haemodynamic effects and long-term treatment.

Authors:  D N Sharpe; J E Douglas; R J Coxon; B Long
Journal:  Lancet       Date:  1980-11-29       Impact factor: 79.321

  5 in total
  2 in total

Review 1.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

2.  Binding and uptake of [3H]adrenaline by perfused rat liver.

Authors:  P H Reinhart; W M Taylor; F L Bygrave
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.